Qualifying Biomarkers to Support Rare Disease Regulatory Pathways: Morning Sessions
3:12:20
Qualifying Biomarkers to Support Rare Disease Regulatory Pathways: Afternoon Sessions
43:33
RWE Webinar: Considerations Regarding Non-Interventional Studies for Drug and Biological Products
2:41:13
Natural History Studies and Registries in the Development of Rare Disease Treatments - Morning
1:05:20
Amazon's 'Everything War' with Dana Mattioli | Masters in Business
3:00:54
Advancing Rare Disease Therapies Through an FDA Rare Disease Innovation Hub
1:01:23
TIL Webinar #3: Essential Steps for Navigating the Tumor-Infiltrating Lymphocyte Journey in Melanoma
1:12:49
Probióticos, piel y sistema inmune: medicina del futuro | Dr. John Gaviria
31:24